DNA Microarray 2013: A Focus on Sales Growth

Home > Biotechnology > Biotechnology Equipment

Market Research Report DNA Microarray 2013: A Focus on Sales Growth
Published by	BioPharm Reports (Technology and Markets Ltd)
Published	February 4, 2013	Product code	250862
Content info	149 Pages
Price	USD 2923 PDF by E-mail (Single User License) USD 3617 PDF by E-mail (Department License) USD 4823 PDF by E-mail (Global License)

Introduction

Introduction

Abstract

DNA Microarray 2013 presents the findings of a global market study of DNA Microarray, involving the participation of 201 buyers and end-users in this field. With a focus on market development, sales growth and commercial opportunities, the study profiled current and evolving areas of this market, as outlined below. Its findings provide valuable product and market information, and decision-making support to suppliers in the DNA Microarray field.

From the early use of miniaturised microarrays for the analysis of gene expression in the mid 1990s, this technique has established markets that are expected to reach $3 billion by 2015. However, these are also changing as new applications are developed and new competitive strategies, such as PCR, grow. This report, based on an analysis of current and evolving developments in the DNA microarray field, has been produced to assist marketing and sales in this field, and the identification of new opportunities. It is the outcome of an extensive global study involving more than 200 experienced DNA microarray buyers and end-users. It's findings provide a “focus on sales growth” to developers and vendors in the microarray field, and the changes that are driving these developments.

The following indicate the key market areas covered in the study:

Routine use: Use of DNA microarrays by end-users for running routine (developed and validated) microarray tests, the development or validation of microarray tests and for the qualitative discovery using microarray methods
Suppliers: Purchases of DNA microarrays and related systems by end-users from more than 30 companies and anticipated DNA microarray purchases by end-users from more than 30 companies over the next three years, each ranked according to their competitive position.
Methods: Current use of more than 15 DNA microarray methods by end-users and the anticipated use of these methods by end-users over the next three years, each ranked according to their competitive position.
Applications: Current use of more than 20 DNA microarray applications by end-users and the anticipated use of these applications by end-users over the next three years, each ranked according to their competitive position.
Preferred Companies: End-users' preferred companies in the DNA microarray field, each ranked according to their competitive position.
Products: End-users' preferred products (and associated companies) in the DNA microarray field, each ranked according to their competitive position.
Strengths: End-users' disclosures of the strengths of their preferred products in the DNA microarray field, each ranked according to their competitive position.
Weaknesses: End-users' disclosures of the weaknesses of their preferred products in the DNA microarray field, each ranked according to their relative position.
Financial Budgets: End-users' annual financial budgets for DNA microarray studies.
Budget Breakdown: The breakdown of end-users' DNA microarray financial budgets in eight key areas, relating to their current expenditure on DNA microarray products and activities.
Future Budget Breakdown: The breakdown of end-users' microarray financial budgets in eight key areas, relating to their anticipated expenditure over the next three years, on DNA microarray products and activities.
Future Budgets: End-users' anticipated changes (percentage increases or decrease) over the next three years, relating to their DNA microarray activities
Consumables: End-users' top three consumables, associated with their DNA microarray activities.
Quality Control: End-users' adherence to established quality control guidelines or procedures (e.g. MAIME), relating to the conduct of DNA microarray studies.
Challenges: End-users' disclosures on molecular types that present the greatest technical challenges to DNA microarray analysis, together with the associated sample types (matrices), associated microarray methods and underlying reasons.
Innovation: End-users' current needs relating to 12 key areas of required innovation in the DNA microarray field, each ranked (on a scale of 1 to 10) according to their importance.
Recent Innovations: End-users disclosures on the most important innovations relating to their use of DNA microarrays, over the last three years.
Future Innovation: End-users' disclosures on what they anticipate will be the most important innovations in the DNA microarray field, over the next three years.
Biomarkers: End-users' application of DNA microarray methods for the study of disease biomarkers, including molecular types and their clinical utilities.
Organisations: End-users organisations include clinics or hospitals, government bodies, large international companies, research institutes, small and medium sized companies, universities and veterinary centres.
Fields: End-users underlying fields include biotechnology, chemicals, clinical or hospital, defence, energy, environmental, food and drink, forensics, geology, government, healthcare, natural products, pharmaceuticals, research institutes, security and universities.
Bioinformatics Software: End-users' disclosures on their preferred bioinformatics software, associated with DNA microarray studies.
Purpose: End-users' underlying reasons for using DNA microarray analysis across 13 major fields (biotechnology, chemicals, clinical or hospital, defence, energy, environmental, food and drink, forensics, geology, government, healthcare, natural products, pharmaceuticals, research institutes, security, university), each ranked according to their relative importance.
Samples: Study sample types analysed by end-users using DNA microarray methods, each ranked according to their relative importance.
Sample Preparation: The use of sample preparation methods by end-users for DNA microarray studies, each ranked according to their importance.

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Study Participants

2.1. This Chapter
2.2. Countries
2.3. Regions
2.4. Organisation Types
2.5. Fields
2.6. Microarray Types
2.7. Participants
2.8. Discussion

Figure 2.1: Countries of individuals who participated in Microarray 2012
Figure 2.2: Global regions of individuals who participated in Microarray 2012.
Figure 2.3: Organisation types of individuals who participated in Microarray 2012
Figure 2.4: Fields of individuals who participated in Microarray 2012
Table 2.1: Countries of individuals who participated in Microarray 2012
Table 2.2: Global regions of individuals who participated in Microarray 2012
Table 2.3: Organisation types of individuals who participated in Microarray 2012

Chapter 3 - DNA Microarray Methods

3.1. This Chapter
3.2. Current Methods
3.3. Future Methods
3.4. Discussion

Figure 3.1: Top ten currently used DNA microarray methods, indicated by individuals who participated in Microarray 2012
Table 3.1: Currently used DNA microarray methods, indicated by individuals who participated in Microarray 2012
Figure 3.2: Other currently used DNA microarray methods, indicated by individuals who participated in Microarray 2012
Table 3.2: Other currently used DNA microarray methods, indicated by individuals who participated in Microarray 2012
Figure 3.3: Top ten DNA microarray methods that end-users anticipate they will be using over the next three years (2012 to 2015), indicated by individuals who participated in Microarray 2012
Table 3.3: DNA microarray methods that end-users anticipate they will be using over the next three years (2012 to 2015), indicated by individuals who participated in Microarray 2012
Figure 3.4: Other DNA microarray methods that end-users anticipate they will be using over the next three years (2012 to 2015), indicated by individuals who participated in Microarray 2012
Table 3.4: Other DNA microarray methods that end-users anticipate they will be using over the next three years (2012 to 2015), indicated by individuals who participated in Microarray 2012

Chapter 4 - DNA Microarray Applications

4.1. This Chapter
4.2. Current Applications
4.3. Future Applications
4.4. Discussion

Figure 4.1: Top ten currently used DNA microarray applications, indicated by individuals who participated in Microarray 2012
Table 4.1: Currently used DNA microarray applications, indicated by individuals who participated in Microarray 2012
Figure 4.2: Other currently used DNA microarray applications, indicated by individuals who participated in Microarray 2012
Table 4.2: Other currently used DNA microarray applications, indicated by individuals who participated in Microarray 2012
Figure 4.3: Top ten DNA microarray applications that end-users anticipate they will be using over the next three years (2012 to 2015), indicated by individuals who participated in Microarray 2012
Table 4.3: DNA microarray applications that end-users anticipate they will be using over the next three years (2012 to 2015), indicated by individuals who participated in Microarray 2012
Figure 4.4: Other DNA microarray applications that end-users anticipate they will be using over the next three years (2012 to 2015), indicated by individuals who participated in Microarray 2012
Table 4.4: Other DNA microarray applications that end-users anticipate they will be using over the next three years (2012 to 2015), indicated by individuals who participated in Microarray 2012

Chapter 5 - Companies

5.1. This Chapter
5.2. Current Companies
5.3. Future Companies
5.4. Discussion

Figure 5.1: Top ten DNA microarray company suppliers, currently used by individuals who participated in Microarray 2012
Table 5.1: DNA microarray company suppliers, currently used by individuals who participated in Microarray 2012
Figure 5.2: Other DNA microarray company suppliers, currently used by individuals who participated in Microarray 2012
Table 5.2: Other DNA microarray company suppliers, currently used by individuals who participated in Microarray 2012
Figure 5.3: Top ten DNA microarray company suppliers that end-users anticipated they will be using over the next three years (2012 to 2015), indicated by individuals who participated in Microarray 2012
Table 5.3: DNA microarray company suppliers that end-users anticipated they will be using over the next three years (2012 to 2015), indicated by individuals who participated in Microarray 2012
Figure 5.4: Other DNA microarray company suppliers that end-users anticipated they will be using over the next three years (2012 to 2015), indicated by individuals who participated in Microarray 2012
Table 5.4: Other DNA microarray company suppliers that end-users anticipated they will be using over the next three years (2012 to 2015), indicated by individuals who participated in Microarray 2012

Chapter 6 - Preferred Companies and Products

6.1. This Chapter
6.2. Current Methods
6.3. Future Methods
6.4. Strengths
6.5. Weaknesses
6.6. Discussion

Figure 6.1: Top ten preferred suppliers in the DNA microarray field, indicated by individuals who participated in Microarray 2012
Table 6.1: Preferred suppliers in the DNA microarray field, indicated by individuals who participated in Microarray 2012
Figure 6.2: Other preferred suppliers in the DNA microarray field, indicated by individuals who participated in Microarray 2012
Table 6.2: Other preferred suppliers in the DNA microarray field, indicated by individuals who participated in Microarray 2012
Figure 6.3: Top ten preferred products in the DNA microarray field, indicated by individuals who participated in Microarray 2012
Table 6.3: Preferred products in the DNA microarray field, indicated by individuals who participated in Microarray 2012
Figure 6.4: Other preferred products in the DNA microarray field, indicated by individuals who participated in Microarray 2012
Table 6.4: Other Top preferred products in the DNA microarray field, indicated by individuals who participated in Microarray 2012
Figure 6.5: Top ten strengths of preferred products in the DNA microarray field, indicated by individuals who participated in Microarray 2012
Table 6.5: Strengths of preferred products in the DNA microarray field, indicated by individuals who participated in Microarray 2012
Figure 6.6: Other strengths of preferred products in the DNA microarray field, indicated by individuals who participated in Microarray 2012
Table 6.6: Other strengths of preferred products in the DNA microarray field, indicated by individuals who participated in Microarray 2012
Figure 6.7: Top ten weaknesses of preferred products in the DNA microarray field, indicated by individuals who participated in Microarray 2012
Table 6.7: Weaknesses of preferred products in the DNA microarray field, indicated by individuals who participated in Microarray 2012
Figure 6.8: Other weaknesses of preferred products in the DNA microarray field, indicated by individuals who participated in Microarray 2012
Table 6.8: Other weaknesses of preferred products in the DNA microarray field, indicated by individuals who participated in Microarray 2012

Chapter 7 - DNA Microarray Expenditure and Budgets

7.1. This Chapter
7.2. Annual Financial Budgets
7.3. Breakdown of Current Financial Budgets
7.4. Breakdown of Future Financial Budgets
7.5. Future Financial Budgets
7.6. Discussion

Figure 7.1: Annual financial budgets for DNA microarray studies, indicated by individuals who participated in Microarray 2012
Table 7.1: Annual financial budgets for DNA microarray studies, indicated by individuals who participated in Microarray 2012
Figure 7.2: The breakdown of current financial budgets for DNA microarray studies, indicated by individuals who participated in Microarray 2012
Table 7.2: The breakdown of current financial budgets for DNA microarray studies, indicated by individuals who participated in Microarray 2012
Figure 7.3: The anticipated future breakdown of financial budgets (over the next three years, 2012 to 2015) for DNA microarray studies, indicated by individuals who participated in Microarray 2012
Table 7.3: The anticipated future breakdown of financial budgets (over the next three years, 2012 to 2015) for DNA microarray studies, indicated by individuals who participated in Microarray 2012

Chapter 8 - Purpose of Microarray Use

8.1. This Chapter
8.2. Purpose
8.3. Discussion

Figure 8.1: Top ten reasons for using DNA microarray in the biotechnology industry, indicated by individuals who participated in Microarray 2012
Figure 8.2: Top ten reasons for using DNA microarray in the Chemicals industry, indicated by individuals who participated in Microarray 2012
Figure 8.3: Top ten reasons for using DNA microarray in clinics or hospitals, indicated by individuals who participated in Microarray 2012
Figure 8.4: Top ten reasons for using DNA microarray in the environmental industry, indicated by individuals who participated in Microarray 2012
Figure 8.5: Top ten reasons for using DNA microarray in the food and drink industry, indicated by individuals who participated in Microarray 2012
Figure 8.6: Top ten reasons for using DNA microarray in the forensics industry, indicated by individuals who participated in Microarray 2012
Figure 8.7: Top ten reasons for using DNA microarray in the Government organisations, indicated by individuals who participated in Microarray 2012
Figure 8.8: Top ten reasons for using DNA microarray in the healthcare industry, indicated by individuals who participated in Microarray 2012
Figure 8.9: Top ten reasons for using DNA microarray in the pharmaceutical industry, indicated by individuals who participated in Microarray 2012
Figure 8.10: Top ten reasons for using DNA microarray in research institutes, indicated by individuals who participated in Microarray 2012
Figure 8.11: Top ten reasons for using DNA microarray in universities, indicated by individuals who participated in Microarray 2012

Chapter 9 - Samples

9.1. This Chapter
9.2. Samples
9.3. Discussion

Figure 9.1: Top ten sample types analysed using DNA microarray, indicated by individuals who participated in Microarray 2012
Table 9.1: Sample types analysed using DNA microarray, indicated by individuals who participated in Microarray 2012

Chapter 10 - Sample Preparation

10.1. This Chapter
10.2. Sample Preparation
10.3. Discussion

Figure 10.1: Top sample preparation methods of DNA microarray users who participated in Microarray 2012
Table 10.1: Sample preparation methods of DNA microarray users who participated in Microarray 2012
Figure 10.2: Other sample preparation methods of DNA microarray users who participated in Microarray 2012
Table 10.2: Other sample preparation methods of DNA microarray users who participated in Microarray 2012

Chapter 11 - Therapeutic Areas

11.1. This Chapter
11.2. Therapeutic Areas
11.3. Discussion

Figure 11.1: Top ten therapeutic areas of DNA microarray users who participated in Microarray 2012
Table 11.1: Therapeutic areas of DNA microarray users who participated in Microarray 2012
Figure 11.2: Other therapeutic areas of DNA microarray users who participated in Microarray 2012
Table 11.2: Other therapeutic areas of DNA microarray users who participated in Microarray 2012

Chapter 12 - Disease Biomarkers

12.1. This Chapter
12.2. Use of Microarray
12.3. Biomarker Types
12.4. Clinical Utility
12.5. Discussion

Figure 12.1: The use of DNA microarray for the study of disease biomarkers, indicated by individuals who participated in Microarray 2012
Figure 12.2: Principal disease biomarkers studied using DNA microarray, indicated by individuals who participated in Microarray 2012
Table 12.1: Other disease biomarkers studied using DNA microarray, indicated by individuals who participated in Microarray 2012
Figure 12.3: Clinical utilities of disease biomarkers studied using DNA microarray, indicated by individuals who participated in Microarray 2012
Table 12.2: Other clinical utilities of disease biomarkers studied using DNA microarray, indicated by individuals who participated in Microarray 2012

Chapter 13 - Bioinformatics Software

13.1. This Chapter
13.2. Bioinformatics Software
13.3. Discussion

Figure 13.1: Top ten bioinformatics software system used for DNA microarray, indicated by users who participated in Microarray 2012
Table 13.1: Bioinformatics software system used for DNA microarray, indicated by users who participated in Microarray 2012
Figure 13.2: Other bioinformatics software system used for DNA microarray, indicated by users who participated in Microarray 2012
Table 13.2: Other bioinformatics software system used for DNA microarray, indicated by users who participated in Microarray 2012

Chapter 14 - Challenging Applications

14.1. This Chapter
14.2. Most challenging Molecular Types
14.3. Most challenging Sample Types (Matrices)
14.4. Microarray Methods Used
14.5. Underlying Reasons
14.6. Discussion

Figure 14.1: The most challenging molecular studies using DNA microarray, indicated by users who participated in Microarray 2012
Table 14.1: The most challenging molecular studies using DNA microarray, indicated by users who participated in Microarray 2012
Figure 14.2: The most challenging sample types (matrices) studies using DNA microarray, indicated by users who participated in Microarray 2012
Table 14.2: The most challenging sample types (matrices) studies using DNA microarray, indicated by users who participated in Microarray 2012
Figure 14.3: Top ten DNA microarrays methods used with the most challenging molecular studies using DNA microarray, indicated by users who participated in Microarray 2012
Table 14.3: DNA microarrays methods used with the most challenging molecular studies using DNA microarray, indicated by users who participated in Microarray 2012
Figure 14.4: Top ten underlying reasons for the challenges encountered using DNA microarray analysis, indicated by users who participated in Microarray 2012
Table 14.4: Underlying reasons for the challenges encountered using DNA microarray analysis, indicated by users who participated in Microarray 2012

Chapter 15 - Innovation

15.1. This Chapter
15.2. Required Innovation
15.3. Recent Innovation
15.4. Future Innovation
15.5. Discussion

Figure 15.1: Top ten most required areas of innovation in DNA microarray, indicated by individuals who participated in Microarray 2012
Table 15.1: Most required areas of innovation in DNA microarray, indicated by individuals who participated in Microarray 2012
Figure 15.2: Other required areas of innovation in DNA microarray, indicated by individuals who participated in Microarray 2012
Table 15.2: Other required areas of innovation in DNA microarray, indicated by individuals who participated in Microarray 2012
Figure 15.3: Top ten recent innovations (in the last three years) in DNA microarray, indicated by individuals who participated in Microarray 2012
Table 15.3: Recent innovations (in the last three years) in DNA microarray, indicated by individuals who participated in Microarray 2012
Figure 15.4: Top ten future anticipated innovations (in the next three years) in DNA microarray, indicated by individuals who participated in Microarray 2012
Table 15.4: Future anticipated innovations (in the next three years) in DNA microarray, indicated by individuals who participated in Microarray 2012

Chapter 16 - Quality Control

16.1. This Chapter
16.2. Quality Control
16.3. Discussion

Figure 16.1: Top ten most commonly used quality control guidelines or procedures used in DNA microarray analysis, indicated by individuals who participated in Microarray 2012
Table 16.1: Quality control guidelines or procedures used in DNA microarray analysis, indicated by individuals who participated in Microarray 2012

Chapter 17 - Discussion

Appendix 1

DNA Microarray 2013: A Focus on Sales Growth published by BioPharm Reports (Technology and Markets Ltd) in February 4, 2013. This report consists of 149 Pages and the price starts from US $ 2923.

The contents of this page may be different from the latest version. Please contact us for details.